Inhibitors of polyq-aggregation
   
   

Compounds of formula I, wherein R.sup.1, R.sup.2, R3, R.sup.4 and R.sup.5 have the meanings as given in claim 1, and their pharmaceutically tolerable derivatives, solvates and stereoisomers and their use for the preparation of a pharmaceutical for inhibiting the formation of polyQ-aggregation. 1

 
Web www.patentalert.com

< 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2- -yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases

< Piperazine derivatives and their use as modulators of nuclear hormone receptor function

> Tocopherol enriched compositions and amelioration of inflammatory symptoms

> Secreted and transmembrane polypeptides and nucleic acids encoding the same
~ 00185